AI Issuer Brief
Arphra AILoading cached brief…
Peers
Price change · trailing returns
Live · FMP| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.14% | -0.01% | +10.83% | +13.87% | +15.02% | +14.64% | +43.05% | +32.08% | +5.95% | -5.80% | +13480.73% |
Aftermarket
Live · FMPLast trade
$90.70
1 sh
Bid
$90.70
5 sh
Ask
$92.00
20 sh
Spread
$1.300
Sector & industry today
Live · FMPSectors
- Technology+0.21%
- Basic Materials+0.15%
- Financial Services-0.43%
- Industrials-0.48%
- Energy-0.58%
- Consumer Defensive-0.79%
- Consumer Cyclical-0.85%
- Real Estate-0.98%
- Healthcare-1.37%
- Communication Services-1.47%
- Utilities-2.07%
Top industries (issuer's industry highlighted)
- Medical - Healthcare Plans-1.08%
- Software - Infrastructure+6.80%
- Coal-6.27%
- Information Technology Services+6.00%
- Medical - Healthcare Information Services+5.23%
- Other Precious Metals+3.84%
- Broadcasting-3.48%
- Silver+2.89%
- Renewable Utilities-2.75%
- Software - Application+2.71%
- Travel Lodging-2.70%
- Internet Content & Information-2.61%
Fair value
Football field →Weighted blend
$484.02
+432.01% vs spot
Recommendation
Strong Buy
17 of 19 methods
Method spread
7bull9bear
±5% threshold
Analyst PT consensus: $95.20 (+4.64%)
Total assets
$261.06B
Total debt
$93.59B
Cash & equiv
$8.51B
Operating CF
$10.64B
Free cash flow
$7.81B
Buybacks
$0
Analyst view
DB · price_targets + analyst_gradesConsensus target
$95.20
+4.64% upside
Low
$90.00
Median
$94.50
High
$101.00
Recent actions
0 ↑0 ↓8 hold
- May 01, 2026
- Apr 01, 2026
- Mar 01, 2026
- Feb 01, 2026
- Jan 01, 2026
News
DB · news_items- Omnicare Receives Court Approval for Sale of Business to GenieRxprnewswire.com·May 13, 2026
- Omnicare Receives Court Approval for Sale of Business to GenieRxprnewswire.com·May 13, 2026
- MinuteClinic highlights access and outcomes in clinically supervised weight-loss programprnewswire.com·May 13, 2026
- CVS Health (CVS) is a Top-Ranked Growth Stock: Should You Buy?zacks.com·May 12, 2026
- CVS Health Stock Hits a New 52-Week High After Posting Strong Q1 Results. Here's Why It Can Still Go Even Higherfool.com·May 12, 2026
- CVS Health (CVS) Stock Slides as Market Rises: Facts to Know Before You Tradezacks.com·May 01, 2026
- Countdown to CVS Health (CVS) Q1 Earnings: Wall Street Forecasts for Key Metricszacks.com·May 01, 2026
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q4 Dec 2025 | $105.69B | $2.94B | $2.30 |
| Q3 Sep 2025 | $102.87B | -$3.98B | $-3.13 |
| Q2 Jun 2025 | $98.92B | $1.02B | $0.80 |
| Q1 Mar 2025 | $94.59B | $1.78B | $1.41 |
| Q4 Dec 2024 | $97.71B | $1.64B | $1.30 |
| Q3 Sep 2024 | $95.43B | $87M | $0.07 |
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
Finucane Anne A. director | Sell | 7,500 | $532.65K | Aug 20, 2025 |
SANSONE GUY P director | Buy | 1,570 | $100.01K | Jun 05, 2025 |
ROBBINS LARRY director | Sell | 150,000 | $10M | May 06, 2025 |
ROBBINS LARRY director | Sell | 1M | $82.65M | May 05, 2025 |
ROBBINS LARRY director | Sell | 96,999 | $6.6M | May 05, 2025 |
ROBBINS LARRY director | Sell | 222,556 | $15.22M | May 02, 2025 |
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2025 | $402.07B | $10.39B | $1.77B | $1.39 | +0.44% |
| FY 2024 | $372.81B | $8.52B | $4.61B | $3.66 | +1.24% |
| FY 2023 | $357.78B | $13.74B | $8.34B | $6.47 | +2.33% |
| FY 2022 | $322.47B | $7.95B | $4.31B | $3.26 | +1.34% |
| FY 2021 | $292.11B | $13.31B | $8B | $5.95 | +2.74% |